Back to Search Start Over

Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients.

Authors :
Tolaney, Sara M.
Ziehr, David R.
Guo, Hao
Ng, Mei R.
Barry, William T.
Higgins, Michaela J.
Isakoff, Steven J.
Brock, Jane E.
Ivanova, Elena V.
Paweletz, Cloud P.
Demeo, Michelle K.
Ramaiya, Nikhil H.
Overmoyer, Beth A.
Jain, Rakesh K.
Winer, Eric P.
Duda, Dan G.
Source :
Oncologist; Aug2021, Vol. 26 Issue 8, pe1483-e1483, 1p
Publication Year :
2021

Abstract

A correction is presented to the article "Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients" which appeared in the October 27, 2016 issue.

Subjects

Subjects :
METASTASIS
PROTEIN-tyrosine kinase inhibitors
TREATMENT effectiveness
CANCER patients
TUMOR markers
BREAST tumors

Details

Language :
English
ISSN :
10837159
Volume :
26
Issue :
8
Database :
Complementary Index
Journal :
Oncologist
Publication Type :
Academic Journal
Accession number :
151755339
Full Text :
https://doi.org/10.1002/onco.13809
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details